The Bottom Line GHK-Cu is a naturally occurring copper tripeptide discovered in 1973 that declines 60% between ages 20 and 60
The drug combines active ingredients semaglutide and amylin analog cargrilintide, and has been touted as a direct competitor of Eli Lillys Zepbound, which uses tirzepatide
Therefore, it is impossible to determine if IN GHK-Cu actually restored the aged hippocampus to a youthful transcriptomic state, or if it pushed the tissue into a novel, alternative compensatory state that simply happens to function better
Material 10 ml Heparinblut Ein Probeneingang im Labor innerhalb von 24 Stunden (24h) muss gewhrleistet sein
PubMedalternative-therapies.com Marketed products carry purity and regulatory risk (grey market, warning letters, athlete sanction risk)
This 10ml vial suits researchers preparing larger volumes or multiple reconstitutions, while the 3ml vial suits smaller, single-use research setups